Vivos Therapeutics (VVOS) Capital Expenditures (2020 - 2026)
Vivos Therapeutics (VVOS) posted quarterly Capital Expenditures of $18000.0 for Q1 2026, down 85.25% year-over-year from $122000.0 in Q1 2025, and down 99.59% quarter-over-quarter from $4.4 million in Q4 2025.
Vivos Therapeutics (VVOS) Capital Expenditures (2020 - 2026) Analysis & Trends
Vivos Therapeutics (VVOS) has reported Capital Expenditures for 7 consecutive years, with $18000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Capital Expenditures fell 85.25% year-over-year to $18000.0; the TTM figure through Mar 2026 stood at $5.1 million (up 842.67% YoY), while the FY2025 annual figure was $5.2 million, up 812.85% from the prior year.
- Capital Expenditures retreated to $18000.0 in Q1 2026 per VVOS's latest filing, from $4.4 million in the prior quarter.
- Across five years, Capital Expenditures topped out at $4.4 million in Q4 2025 and bottomed at -$434000.0 in Q3 2023.
- Historically, Capital Expenditures has averaged $441058.8 across 5 years, with a median of $151000.0 in 2024.
- Annual changes were most pronounced in 2023 — Capital Expenditures plunged 534.0% — and 2025, when it jumped 2551.52%.
- Vivos Therapeutics' Capital Expenditures stood at $200000.0 in 2022, then jumped by 276.5% to $753000.0 in 2023, then plunged by 78.09% to $165000.0 in 2024, then surged by 2551.52% to $4.4 million in 2025, then sank by 99.59% to $18000.0 in 2026.
- Business Quant data shows VVOS's Capital Expenditures at $18000.0 in Q1 2026, $4.4 million in Q4 2025, and -$83000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 497.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 202.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 488.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 195.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 66.90 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 84.70 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 100.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -74.39 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 87.50 Mn |
| 10 | Vivos Therapeutics | 4.94 Mn | 3.14 Mn | 2.95 Mn | 416,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18,000.00 |
| Mar 31, 2026 | 18,000.00 |
| Dec 31, 2025 | 4.38 Mn |
| Dec 31, 2025 | 4.38 Mn |
| Sep 30, 2025 | -83,000.00 |
| Sep 30, 2025 | -83,000.00 |
| Jun 30, 2025 | 771,000.00 |
| Jun 30, 2025 | 771,000.00 |
| Mar 31, 2025 | 122,000.00 |
| Mar 31, 2025 | 122,000.00 |
| Dec 31, 2024 | 165,000.00 |
| Dec 31, 2024 | 165,000.00 |
| Sep 30, 2024 | 192,000.00 |
| Sep 30, 2024 | 192,000.00 |
| Jun 30, 2024 | 60,000.00 |
| Jun 30, 2024 | 60,000.00 |
| Mar 31, 2024 | 151,000.00 |
| Mar 31, 2024 | 151,000.00 |
| Dec 31, 2023 | 753,000.00 |
| Dec 31, 2023 | 753,000.00 |